Since 2018 I am the CEO of the Swiss Biotech Association. Our mission is to support the > 1'700 Swiss biotech startups and SMEs by providing online matching platforms and networking event. See, e.g. www.swissbiotch.org/companies, www.swissbiotechday.ch
Dr. Michael Altorfer is the CEO of the Swiss Biotech Association since 2018. He has more than 25 years of experience in the life science industry comprising both big pharma and smaller biotech organizations. As a member of the Executive Committee, he supported the build-up of Polyphor Ltd in Allschwil in many different roles (Head BD&L, CFO, COO and CEO). Michael started his career as a scientist in pharmaceutical research at Sandoz, Ciba-Geigy (Summit, NJ, USA), and Roche. From 1996 to 2001 he held program management and line management roles at the investment bank UBS Warburg.
Michael studied Natural Sciences at the ETH and he obtained his Ph.D. in Chemistry under the supervision of Prof. Dr. H.-J. Hansen (University of Zurich) and Prof. Dr. K. Müller (Roche) and holds an MBA degree from the University of Rochester, NY, USA.
Use the Swiss Biotech Day and the embedded Global Village platform to connect with Swiss R&D, business and investment partners.
www.swissbiotechday.ch
www.swissbiotech.org/global-village
Every year, the Swiss Biotech Association, together with 7 report partners, publishes an update on the trends, achievements, key transactions, highlights and the funding of the Swiss biotech industry. www.swissbiotech.org/report
The Swiss Biotech Day is a global biotech conference that typically takes place at the end of April/early May. It is organized by the Swiss Biotech Association and its logistics partner Bamconn.